Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17498252

Download in:

View as

General Info

PMID
17498252